🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
3 STUDY RATIONALE Based upon the above rationale, the investigators propose...
Status
Completed
Location
Duke Cancer Institute
Start Date
2011-12
Trial ID
NCT01485042
Treatments Being Tested
SARC021C is a nonrandomized, open-label, multicenter, continuation study de...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT02712567
Treatments Being Tested
The Primary Objectives are: * To determine the extent by which TH-302 is a...
Status
Completed
Location
Cancer Therapy & Research Center at UTHSCSA
Start Date
2011-06
Trial ID
NCT01403610
Treatments Being Tested
This is a multicenter, open-label, Phase 1, dose escalation trial to evalua...
Status
Terminated
Location
Mayo Clinic
Start Date
2014-01
Trial ID
NCT02047500
Treatments Being Tested
This phase 2 study is designed to evaluate the safety and tolerability acti...
Status
Unknown
Location
Pacific Cancer Care
Start Date
2012-02
Trial ID
NCT01522872
The purpose of this Phase 1/2 study is to test the overall safety, tolerabi...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2025-01-08
Trial ID
NCT06782555
Treatments Being Tested
The primary objective of this phase I dose escalation study is to determine...
Status
Unknown
Location
Scripps Clinic
Start Date
2014-12
Trial ID
NCT01721941
Treatments Being Tested
RATIONALE: Sorafenib tosylate may stop the growth of tumor cells by blockin...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2012-05
Trial ID
NCT01497444
Treatments Being Tested
The purpose of this study is to determine whether TH-302 in combination wit...
Status
Terminated
Location
UAB Cancer Center
Start Date
2014-06
Trial ID
NCT02093962
Treatments Being Tested
Open-label, single-center phase 1 study of an investigational agent TH-302 ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02598687
Treatments Being Tested